US5276057A
Expired / Lapsed
US
⏱️ 0.0 years remaining
L-deprenyl for treating immune system dysfunction
Assignee: DEPRENYL Inc USA
•
Filing: 1992-11-12
•
Granted: 1994-01-04
•
Expires: 2012-11-12
Abstract
Abstract Use of l-deprenyl for treatment of immune system dysfunction for mammals.
Inventors
- 👤 Norton W. Milgram
- 👤 David R. Stevens
- 👤 Gwendolyn O. Ivy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 13:46
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/137; A61P; A61P13/00; A61P13/02; A61P15/00; A61P25/00; A61P25/28; A61P3/00; A61P37/00; A61P43/00; A61P5/00; A61P5/10; A61P5/12; A61P5/38
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
75 words
A method of treating immune system dysfunction of humoral antibody response and T lymphocyte function of non-human mammals, said method comprising: administering to the non-human mammal a small but humoral antibody response and T lymphocyte dysfunction treating effective amount of the compound l-deprenyl, or a pharmaceutically acceptable form thereof, at a frequency level of from about one to about seven times weekly until a desired effect upon deterioration of immune system response function is achieved.
Claim 2
Independent Claim
75 words
A method of treating immune system dysfunction of humoral antibody response and T lymphocyte function of non-human mammals, said method comprising: administering to the non-human mammal a small but humoral antibody response and T lymphocyte dysfunction treating effective amount of the compound l-deprenyl, or a pharmaceutically acceptable form thereof, at a frequency level of from about one to about seven times weekly until a desired effect upon deterioration of immune system response function is achieved.
Claim 3
Dependent Claim
15 words
The method of claim 1 wherein the l-deprenyl is the hydrochloride addition salt form thereof.
Claim 4
Dependent Claim
26 words
The method of claim 1 wherein the addition level is at a level of from 0.1 mg/kg of body weight to 5.0 mg/kg of body weight.
Claim 5
Dependent Claim
31 words
The method of claim 3 wherein the addition level is from about 0.1 mg/kg of body weight to about 5.0 mg/kg of body weight, dosed from one to seven times weekly.
References Cited (Backward Citations)
CA871155A
Cited
US4564706A
Cited
CA1215394A
Cited
US4916151A
Cited
US4871550A
Cited
US4880883A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-01-03 | 1997-07-05 | 1998-01-04 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-01-03 | 2001-07-05 | 2002-01-04 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-01-03 | 2005-07-05 | 2006-01-04 | $7700.00 | Window Closed / Lapsed |